A pharmacist writes that FDA scientists recommended against all seven peptides reviewed, and warns the policy could weaken incentives to run real trials.
Recap by typeshit. Full story at BioSpace.
The unapproved Lilly drug was confiscated in a dozen enforcement raids, part of a growing crackdown on gray-market retatrutide sellers.
An FDA lawyer explains enforcement discretion, and ASOP Global warns illegal online sellers can now blend in with compliant ones.
KKM says it has seized 759 units of GLP-1 receptor agonist products worth RM405,170 since 2025 in its crackdown on unlicensed sellers.
Bhekisisa reports South Africa's regulator sees sellers on WhatsApp, Facebook and X. Inspectors close one down and another quickly takes its place.
A shared report on doctors turning to GLP-1 medications for weight loss in some kids. Details are thin, so tap through for the full story.
Zeus Hygia reports its berberine extract raised GLP-1 levels in a 14-day, 36-person trial, but warns brands against 'nature's Ozempic' comparisons.
Loading…